Sention Technologies has secured a £3.7m seed round to commercialise its battery diagnostics technologies.
The London-based firm is aiming to redefine battery diagnostics with a rapid, low-cost solution that combines non-invasive ultrasonic scanning and AI-driven data analysis.
Its proprietary scanning technology lets manufacturers ‘see inside’ batteries by listening to them, enabling accurate health assessments, failure predictions and waste reduction without opening or damaging the cells.
The round was led by Twin Path Ventures and joined by Green Angel Ventures, Doral Energy-Tech Ventures, Endgame Capital, Energy Revolution Ventures, G.K. Goh Ventures, Third Sphere and UK Innovation and Science Seed Fund.
The company will also use the funds to accelerate the commercialisation of its Senturion ultrasound instruments that offer real-time 3D scanning of the internal structure of batteries, as well as its AI-driven data fusion software, Sentinel.
On top of that, the business will invest in R&D for its next-generation product, Sentry, designed to integrate directly into production lines.
Additional funding will support international customer acquisition.
“This funding represents a significant milestone for Sention as we continue to innovate at the forefront of battery diagnostics,” said Dan Brett, co-founder and CEO of Sention.
“We are grateful to our investors for supporting our mission to enable the electrochemical power revolution by enhancing the performance, quality, and safety of batteries.”
Cam Ross, CEO of Green Angel Ventures, added: “We are excited to back Sention’s advanced diagnostic technology.
By reducing waste, improving efficiency, and enhancing safety, this technology supports a more sustainable battery industry, helping to meet the growing demand for cleaner energy solutions.”